Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Viking Thera (VKTX)

Viking Thera (VKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Viking Thera 9920 PACIFIC HEIGHTS BLVD SUITE 350 SAN DIEGO CA 92121 USA

www.vikingtherapeutics.com Employees: 36 P: 858-704-4660

Sector:

Medical

Description:

Viking Therapeutics, Inc. is a biopharmaceutical company. The company is engaged in development of novel therapies for metabolic and endocrine disorders. Its product candidate consists of VK5211, VK0214, VK0612 and VK2809 which are in different clinical trial. Viking Therapeutics, Inc. is based in LA JOLLA, United States.

Key Statistics

Overview:

Market Capitalization, $K 4,359,799
Enterprise Value, $K 4,333,119
Shares Outstanding, K 113,036
Annual Sales, $ 0 K
Annual Net Income, $ -109,960 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -90,790 K
EBIT, $ -274,840 K
EBITDA, $ -291,670 K
60-Month Beta 0.65
% of Insider Shareholders 4.10%
% of Institutional Shareholders 76.03%
Float, K 108,402
% Float 95.90%
Short Volume Ratio 0.33

Growth:

1-Year Return -24.73%
3-Year Return 948.10%
5-Year Return 513.20%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth -180.56%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.81 on 10/22/25
Next Earnings Date N/A
Earnings Per Share ttm -2.12
EPS Growth vs. Prev Qtr -39.66%
EPS Growth vs. Prev Year -268.18%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

VKTX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -29.35%
Return-on-Assets % -28.41%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 5.37
Book Value/Share 6.31
Interest Coverage -1.23
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar